Botulinum toxin type B (Myobloc)

BIOLOGICAL2 trials

Sponsors

The University of Texas Health Science Center at San Antonio, Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC

Conditions

Amyotrophic Lateral SclerosisDroolingSialorrhea

Phase 2

Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)

CompletedNCT00125203

The University of Texas Health Science Center at San AntonioAmyotrophic Lateral Sclerosis, Sialorrhea

Start: 2003-07-31End: 2007-08-31Target: 20Updated: 2012-03-14

A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients

CompletedNCT00515437

Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLCDrooling

Start: 2007-07-01End: 2008-09-01Updated: 2026-04-21